Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation

Area of Science:

• Cardiology and Cardiovascular Diseases
• Clinical Medicine

Background:

• Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in the U.S., posing significant health challenges.
• AF is strongly linked to increased risks of stroke, heart failure, and overall mortality.
• Existing risk scores like CHADS₂ and CHA₂DS₂-VASc aid in assessing stroke risk and guiding treatment in AF patients.

Purpose of the Study:

• To review the impact of atrial fibrillation on major adverse cardiovascular events (MACE).
• To elucidate the relationship between AF and outcomes in stroke, coronary artery disease (CAD), and peripheral vascular disease (PVD).
• To highlight the association between AF, atherosclerosis, and myocardial infarction (MI).

Main Methods:

• Literature review synthesizing current evidence on atrial fibrillation and cardiovascular outcomes.
• Analysis of the interplay between AF pathophysiology and other cardiovascular diseases.
• Examination of risk factors common to both AF and atherosclerosis.

Main Results:

• Atrial fibrillation is an independent predictor of increased total mortality.
• AF is a major risk factor for thromboembolic stroke.
• The presence of AF complicates the clinical course of myocardial infarction and is linked to coronary and peripheral vascular disease.

Conclusions:

• Atrial fibrillation significantly elevates the risk of major adverse cardiovascular events and mortality.
• Understanding AF's impact on stroke, CAD, and PVD is crucial for comprehensive patient management.
• Shared risk factors underscore the link between AF, atherosclerosis, and other cardiovascular conditions.